<akomaNtoso xmlns:uk="https://www.legislation.gov.uk/namespaces/UK-AKN" xmlns:ukl="http://www.legislation.gov.uk/namespaces/legislation" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0" xsi:schemaLocation="http://docs.oasis-open.org/legaldocml/ns/akn/3.0 http://docs.oasis-open.org/legaldocml/akn-core/v1.0/cos01/part2-specs/schemas/akomantoso30.xsd"><act name="eur"><meta><identification source="#"><FRBRWork><FRBRthis value="http://www.legislation.gov.uk/id/eur/2020/2002"/><FRBRuri value="http://www.legislation.gov.uk/id/eur/2020/2002"/><FRBRdate date="2020-12-07" name="adopted"/><FRBRauthor href=""/><FRBRcountry value="EU"/><FRBRnumber value="2002"/><FRBRname value="Regulation (EU) 2020/2002"/><FRBRprescriptive value="true"/></FRBRWork><FRBRExpression><FRBRthis value="http://www.legislation.gov.uk/eur/2020/2002/2020-12-07"/><FRBRuri value="http://www.legislation.gov.uk/eur/2020/2002/2020-12-07"/><FRBRdate date="2020-12-07" name="validFrom"/><FRBRauthor href="#"/><FRBRlanguage language="eng"/></FRBRExpression><FRBRManifestation><FRBRthis value="http://www.legislation.gov.uk/eur/2020/2002/2020-12-07/data.akn"/><FRBRuri value="http://www.legislation.gov.uk/eur/2020/2002/2020-12-07/data.akn"/><FRBRdate date="2026-08-18+01:00" name="transform"/><FRBRauthor href="http://www.legislation.gov.uk"/><FRBRformat value="application/akn+xml"/></FRBRManifestation></identification><lifecycle source="#"><eventRef refersTo="#adopted" date="2020-12-07" eId="date-adopted" source="#"/><eventRef date="2020-12-07" eId="date-2020-12-07" source="#"/></lifecycle><analysis source="#"><restrictions source="#"><restriction refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#body" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#article-11" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction refersTo="#period-from-2020-12-07" type="jurisdiction"/><restriction href="#body" refersTo="#period-from-2020-12-07" type="jurisdiction"/><restriction href="#article-11" refersTo="#period-from-2020-12-07" type="jurisdiction"/></restrictions><otherAnalysis source=""/></analysis><temporalData source="#"><temporalGroup eId="period-from-2020-12-07"><timeInterval start="#date-2020-12-07" refersTo="#"/></temporalGroup></temporalData><references source="#"><TLCEvent eId="adopted" href="" showAs="AdoptedDate"/><TLCLocation eId="extent-e+w+s+ni" href="/ontology/jurisdictions/uk.EnglandWalesScotlandNorthernIreland" showAs="E+W+S+N.I."/></references><proprietary xmlns:ukm="http://www.legislation.gov.uk/namespaces/metadata" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" source="#"><dc:identifier>http://www.legislation.gov.uk/eur/2020/2002/article/11</dc:identifier><dc:title>Commission Implementing Regulation (EU) 2020/2002 of 7 December 2020 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to Union notification and Union reporting of listed diseases, to formats and procedures for submission and reporting of Union surveillance programmes and of eradication programmes and for application for recognition of disease-free status, and to the computerised information system (Text with EEA relevance)</dc:title><dct:alternative>Commission Implementing Regulation (EU) 2020/2002</dct:alternative><dc:description>Commission Implementing Regulation (EU) 2020/2002 of 7 December 2020 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to Union notification and Union reporting of listed diseases, to formats and procedures for submission and reporting of Union surveillance programmes and of eradication programmes and for application for recognition of disease-free status, and to the computerised information system (Text with EEA relevance)</dc:description><dc:modified>2020-12-10</dc:modified><dc:publisher>King's Printer of Acts of Parliament</dc:publisher><dc:source>https://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32020R2002</dc:source><dc:type>text</dc:type><dc:format>text/xml</dc:format><dc:language>en</dc:language><dct:valid>2020-12-07</dct:valid><ukm:EUMetadata><ukm:DocumentClassification><ukm:DocumentCategory Value="euretained"/><ukm:DocumentMainType Value="EuropeanUnionRegulation"/><ukm:DocumentStatus Value="revised"/></ukm:DocumentClassification><ukm:Year Value="2020"/><ukm:Number Value="2002"/><ukm:EURLexIdentifiers xmlns:atom="http://www.w3.org/2005/Atom" xmlns="http://www.legislation.gov.uk/namespaces/legislation"><ukm:Cellar Value="1fa8a4d2-391e-11eb-b27b-01aa75ed71a1"/><ukm:OfficialJournal Value="JOL_2020_412_R_0001"/><ukm:ELI Value="reg_impl:2020:2002:oj"/><ukm:CELEX Value="32020R2002"/></ukm:EURLexIdentifiers><ukm:EnactmentDate Date="2020-12-07"/><ukm:EURLexModified Date="2020-12-10T06:45:10Z"/><ukm:EURLexExtracted Date="2020-12-10T08:57:20Z"/><ukm:XMLGenerated Date="2020-12-10T08:57:24Z"/><ukm:XMLImported Date="2020-12-10T09:34:39Z"/><ukm:Treaty Title="Treaty on the Functioning of the European Union (consolidated version 2012)" Code="TFEU_2012"/><ukm:CreatedBy Label="Directorate-General for Health and Food Safety" URI="http://publications.europa.eu/resource/authority/corporate-body/SANTE"/><ukm:CreatedBy Label="European Commission" URI="http://publications.europa.eu/resource/authority/corporate-body/COM"/><ukm:Subject Scheme="EuroVoc" Label="exchange of information" URI="http://eurovoc.europa.eu/616"/><ukm:Subject Scheme="EuroVoc" Label="animal disease" URI="http://eurovoc.europa.eu/1755"/><ukm:Subject Scheme="EuroVoc" Label="EU Member State" URI="http://eurovoc.europa.eu/5283"/><ukm:Subject Scheme="EuroVoc" Label="veterinary medicine" URI="http://eurovoc.europa.eu/1856"/><ukm:Subject Scheme="SubjectMatter" Label="Veterinary legislation" URI="http://publications.europa.eu/resource/authority/subject-matter/VETE"/><ukm:Subject Scheme="EuroVoc" Label="health risk" URI="http://eurovoc.europa.eu/3730"/><ukm:Subject Scheme="EuroVoc" Label="protection of animal life" URI="http://eurovoc.europa.eu/2826"/><ukm:Subject Scheme="EuroVoc" Label="disease prevention" URI="http://eurovoc.europa.eu/1854"/><ukm:Subject Scheme="EuroVoc" Label="epidemic" URI="http://eurovoc.europa.eu/837"/><ukm:Subject Scheme="EuroVoc" Label="zoonosis" URI="http://eurovoc.europa.eu/6152"/><ukm:Subject Scheme="EuroVoc" Label="veterinary inspection" URI="http://eurovoc.europa.eu/1445"/><ukm:Subject Scheme="DirectoryCode" Label="Animal health and zootechnics" URI="http://publications.europa.eu/resource/authority/fd_555/035030"/><ukm:Subject Scheme="DirectoryCode" Label="Approximation of laws and health measures" URI="http://publications.europa.eu/resource/authority/fd_555/0350"/><ukm:Subject Scheme="DirectoryCode" Label="Agriculture" URI="http://publications.europa.eu/resource/authority/fd_555/03"/><ukm:DocumentCurrentStatus><ukm:UKAmended Value="false"/></ukm:DocumentCurrentStatus></ukm:EUMetadata><ukm:Alternatives><ukm:Alternative URI="http://www.legislation.gov.uk/eur/2020/2002/pdfs/eur_20202002_adopted_en.pdf" Date="2020-12-07" Size="648333"/></ukm:Alternatives><ukm:Statistics><ukm:TotalParagraphs Value="69"/><ukm:BodyParagraphs Value="14"/><ukm:ScheduleParagraphs Value="55"/><ukm:AttachmentParagraphs Value="0"/><ukm:TotalImages Value="0"/></ukm:Statistics></proprietary></meta><body eId="body"><article eId="article-11" uk:target="true"><num>Article 11</num><heading>Application for recognition of disease-free status of Member States and zones as regards diseases of terrestrial and aquatic animals and disease-free status of compartments as regards diseases of aquatic animals</heading><paragraph eId="article-11-1"><num>1.</num><intro><p>Member States shall, when applying to the Commission for recognition of disease-free status in accordance with Sections 1 and 2 of Chapter 4 of Part II of Delegated Regulation (EU) 2020/689, include in their applications the relevant information specified in:</p></intro><level class="para1"><num>(a)</num><content><p>Sections 1 and 2 of Annex VI if the application for recognition of disease-free status is based on the absence of listed species;</p></content></level><level class="para1"><num>(b)</num><content><p>Sections 1 and 3 of Annex VI if the application for recognition of disease-free status is based on the disease agent’s incapacity to survive;</p></content></level><level class="para1"><num>(c)</num><content><p>Sections 1 and 4 of Annex VI if the application for recognition of disease-free status is based on the incapacity to survive of listed vectors for listed diseases of terrestrial animals;</p></content></level><level class="para1"><num>(d)</num><content><p>Sections 1 and 5 of Annex VI if the application for recognition of disease-free status is based on historical and surveillance data;</p></content></level><level class="para1"><num>(e)</num><content><p>Section 1 and point 1 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for infection with <i>Brucella abortus, B. melitensis</i> and <i>B. suis</i> as regards kept bovine animals;</p></content></level><level class="para1"><num>(f)</num><content><p>Section 1 and point 2 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for infection with <i>Brucella abortus, B. melitensis</i> and <i>B. suis</i> as regards kept ovine and caprine animals;</p></content></level><level class="para1"><num>(g)</num><content><p>Section 1 and point 3 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for infection with MTBC;</p></content></level><level class="para1"><num>(h)</num><content><p>Section 1 and point 4 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for enzootic bovine leukosis (EBL);</p></content></level><level class="para1"><num>(i)</num><content><p>Section 1 and point 5 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV);</p></content></level><level class="para1"><num>(j)</num><content><p>Section 1 and point 6 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for infection with Aujeszky’s disease virus (ADV);</p></content></level><level class="para1"><num>(k)</num><content><p>Section 1 and point 7 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for bovine viral diarrhoea (BVD);</p></content></level><level class="para1"><num>(l)</num><content><p>Section 1 and point 8 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for infection with RABV;</p></content></level><level class="para1"><num>(m)</num><content><p>Section 1 and point 9 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for infection with BTV;</p></content></level><level class="para1"><num>(n)</num><content><p>Section 1 and, where relevant, point 10 of Section 6 of Annex VI if the application for recognition of disease-free status is based on eradication programmes for diseases of aquatic animals.</p></content></level></paragraph><paragraph eId="article-11-2"><num>2.</num><intro><p>Applications for recognition of disease-free status of compartments shall contain, in addition to the information referred to in point (n) of paragraph 1, the following information:</p></intro><level class="para1"><num>(a)</num><content><p>in case of compartments referred to in point (a) of Article 73(2) of Delegated Regulation (EU) 2020/689, documentation that substantiates compliance with the requirements provided for in Article 79(3), (4) and (5) of that Delegated Regulation;</p></content></level><level class="para1"><num>(b)</num><content><p>in case of compartments referred to in point (b) of Article 73(2) of Delegated Regulation (EU) 2020/689, the assessment referred to in point (a) of Article 73(3) of that Delegated Regulation and details of any measures, which were put in place to prevent the introduction of the disease concerned into the compartment as referred to in point (c) of Article 73(3) of that Delegated Regulation.</p></content></level></paragraph><paragraph eId="article-11-3"><num>3.</num><content><p>Member States shall inform the Commission immediately about any confirmed case of the relevant disease that is detected in the territory concerned after the date of submission of applications for recognition of disease-free status and before the date of recognition of that status.</p></content></paragraph><paragraph eId="article-11-4"><num>4.</num><content><p>The applications referred to in paragraphs 1 and 2 shall be submitted electronically via the ADIS.</p></content></paragraph></article></body></act></akomaNtoso>